E-cigarettes raise concern for potential health risk
A systemic review reveals a new side to e-cigarettes
E-cigarettes are not safe as people think.
In a recent systematic review and meta-analysis published in the journal BMC Public Health, researchers investigated the association between the use of electronic cigarette (e-cigarette) and the risk of myocardial infarction (MI aka heart attack) as well as stroke.
For decades, cigarette smoking has been recognized as a major risk factor for coronary artery disease, hypertension, and stroke.
In response, the tobacco industry introduced electronic nicotine delivery systems (ENDS), commonly referred to as e-cigarettes or “vapes,” and promoted them as harm-reduction tools to aid smoking cessation.
The present study addressed this gap using a systematic review and meta-analysis (SRMA) conducted in accordance with the 2020 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
Conventional cigarette smoking was treated as a key confounder and subgroup variable.
Analysis showed that people who used e-cigarettes had 53% higher chances of MI compared with non-users.
Notably, among former cigarette smokers who currently use e-cigarettes, the odds of a heart attack were more than doubled.
These findings raise concerns about the cardiovascular safety of e-cigarettes and indicate that they should not be assumed to be risk-free alternatives, especially for cigarettes.
This systematic review suggested that e-cigarette use is associated with increased odds of myocardial infarction, particularly among individuals with a history of cigarette smoking.
Although exclusive vaping among never-smokers was not associated with statistically significant cardiovascular risk in this analysis, the elevated risk observed in former smokers raises concerns about the use of e-cigarettes as a harm-reduction tool.
-
Some grief never goes away—Scientists now know why
-
E-cigarettes: A proving quitting tool that still carries health risks
-
Eli Lilly expands $2.75B AI-enabled drug discovery deal with Insilico Medicine
-
London sewage detects polio weeks after funding drop
-
COVID-19 ‘Cicada’ variant: Here’s everything to know
-
Eye drops made from pig body fluid could revolutionize cancer treatment, new study says
-
Paul Conyngham uses ChatGPT, AlphaFold to develop a life-saving cancer vaccine for his dog
-
'Cicada' COVID variant detected in multiple countries as experts study mutation risks
